Summit Therapeutics Inc. (SMMT) Insider Trading

Name: Summit Therapeutics Inc. (SMMT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 12, 2026): Zanganeh Mahkam (Co-Chief Executive Officer): Purchase of 3,810,000 shares, $49.99M.

Get alerted when insiders trade SMMT

Email address

Loading company data...

Beta

Loading company details...

Beta